Benzyl alcohol at 0.9% concentration
Many people read, use their phone, listen to music, or rest
The TRIUMPH-1 Phase 3 clinical trial results, announced in May 2026, showcased participants losing up to 28.3% of their body weight over 80 weeks, indicating significant promise compared to other options like tirzepatide (Zepbound) and semaglutide (Wegovy)
DKA, which can be triggered by missed insulin doses, infections, or stress, requires immediate medical treatment with fluids, insulin, and electrolyte replacement
Quality Control Rigorous quality checks and WHO-GMP certified storage facilities ensure product integrity